Black Lung Cancer Patients Receiving Immunotherapy May Fare Better Than White Patients
Black patients experience higher lung cancer mortality than white patients, but equal access to immunotherapy may help close the...
Black patients experience higher lung cancer mortality than white patients, but equal access to immunotherapy may help close the...
PHILADELPHIA – A study that tracked parental opinion about the human papillomavirus (HPV) vaccine showed that after hesitancy decreased...
PHILADELPHIA – Black/African American patients with prostate cancer who were treated with the androgen receptor inhibitor darolutamide (Nubeqa) had...
Modifying criteria could help researchers enroll more Black patients in trials PHILADELPHIA – A simulated pancreatic cancer clinical trial...
PHILADELPHIA – Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival...
PHILADELPHIA – Men who had a high genetic risk of developing prostate cancer were less likely to develop a...
PHILADELPHIA – A combination of copanlisib (Aliqopa) and rituximab led to a 48 percent reduction in the risk of...
PHILADELPHIA – Tumor mutational burden (TMB) was an accurate predictor of response to treatment with immune checkpoint inhibitors for...
PHILADELPHIA – A liquid biopsy test to assess plasma cell-free DNA (cfDNA) integrity could improve the accuracy of magnetic...
PHILADELPHIA – Treatment with the neoantigen cancer vaccine PGV-001 following standard-of-care adjuvant therapy was well tolerated and showed potential...